about
High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damageResults from Polish Spondyloarthritis Initiative registry (PolSPI) - methodology and data from - the first year of observationPulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients.Yttrium-90 distribution following radiosynoviorthesis of the knee joint in rheumatoid arthritis patients: a SPECT/CT study.The relation of rapid changes in obesity measures to lipid profile - insights from a nationwide metabolic health survey in 444 Polish cities.Pharmacological management of hypertension in the elderly--certitudes and controversies.The prevalence of falls and their relation to visual and hearing impairments among a nation-wide cohort of older Poles.Relationship between gender and clinical characteristics, associated factors, and hypertension treatment in patients with resistant hypertension.There is more to salt than just a pinch of sodium.Intima-media thickness of carotid artery and aortic pulse wave velocity as determinants of cerebral blood flow velocity.Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.Disparate effects of anti-TNF-α therapies on measures of disease activity and mediators of endothelial damage in ankylosing spondylitis.The FGA Thr312Ala polymorphism and risk of intracerebral haemorrhage in Polish and Greek populations.Twenty-four-hour and conventional blood pressure components and risk of preterm delivery or neonatal complications in gestational hypertension.Subclinical Mood and Cognition Impairments and Blood Pressure Control in a Large Cohort of Elderly Hypertensives.The absolute number of circulating nonclassical (CD14+CD16++) monocytes negatively correlates with DAS28 and swollen joint count in patients with peripheral spondyloarthritis.Conventional and 24-h ambulatory blood pressure as independent predictors of elastic arterial properties.The relation between blood pressure components and left atrial volume in the context of left ventricular mass index.Safety vs Efficacy of Lowering Blood Pressure.The relation between ACE D/I and CYP11B2 C-344T polymorphisms and parameters of arterial stiffness in the context of renal sodium handling.Arterial characteristics in normotensive offspring of parents with or without a history of hypertension.Potentially positive ageing-related variations of medial smooth muscle cells in the saphenous veins used as aortocoronary bypass grafts.Blood pressure, arterial stiffness and endogenous lithium clearance in relation to AGTR1 A1166C and AGTR2 G1675A gene polymorphisms.Blood Pressure Target: High Time That We Finally Agreed What Is Healthy.Arterial hypertension after age 65: from epidemiology and pathophysiology to therapy Do we know where we stand?Are ACE inhibitors acceptable ingredients in polypills?Is "Usual" Blood Pressure a Proxy for 24-h Ambulatory Blood Pressure in Predicting Cardiovascular Outcomes?Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysisResponse to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic HypertensionClinical trials in isolated systolic hypertensionBlood pressure in centenarians in PolandDaytime, home and office blood pressures in treated hypertensive patients according to accretion of cardiovascular riskPulse wave velocity in patients with coronary artery disease or type 2 diabetes mellitusAntioxidative protection in hypertensive patients treated with diureticsThe relationship between pulse wave velocity and indexes of collagen synthesis in hypertensive patients, according to the level of systolic blood pressureBreast cancer, age, and hypertension: a complex issueSystolic swing of the pendulum: relation between hypertension and heart failure revisitedHeart failure and atrial fibrillation--does practice meet the anticoagulation guidelines?2015 guidelines for the management of hypertension. Recommendations of the Polish Society of Hypertension - short versionBlood pressure and arterial stiffness in patients with high sodium intake in relation to sodium handling and left ventricular diastolic dysfunction status
P50
Q31113598-6CACD7F5-DEDA-4704-93A0-3DE1686E371FQ33720765-D259D85A-1A84-4D45-9810-2076DE31B469Q33900110-A45534A8-45DA-42A3-986D-B372DBC3ABDEQ34054668-F92C7E1A-D07C-4543-8948-8795C0341E71Q37538208-A6903B45-7EC9-404B-8F49-01E1AFF6DA94Q38196897-8969698C-45B8-47B1-8798-C4893B7FD375Q39499106-1A6B9ADA-027C-4951-B9B1-D0D7D7841545Q40354734-E717FBC0-8BD6-4390-A339-39E6F850A753Q43470142-6E5AA7F9-5D1B-4F5E-9CF6-8FCEC4D27455Q44600097-B5F5E568-89F9-4C96-92FC-4F98CB609D64Q44624124-C6D238D7-2DFC-4926-BBED-194586AFAF8FQ45940282-137BDC63-6393-4985-9322-1B1558CE6939Q46651865-9D66781A-6659-4072-80C1-8D0D82DD9B08Q47847480-A850F672-1628-4050-81EE-8C95C23562AAQ47964591-20501979-B138-4A9C-B41D-80013A8BAE99Q48560079-35425602-6D07-4B3E-99A9-003033F0219DQ48859805-3F107FD6-61DC-4B2B-97A1-1EB591415AD0Q49557096-1A54569A-1D13-490F-B580-B104F9B6DCADQ49589999-4BF5C367-BF5A-461A-8ADD-94625CEBAB25Q51000382-3747BD79-1906-4005-BF41-6E06398648AFQ51261232-9CD17C3C-246C-45DC-A8A2-EE3E832F88A1Q51326821-8D8DD337-0AC9-440E-A247-D0030DF4236DQ51684297-8B6E4B4D-3D7F-4231-9022-914BE6945160Q51813618-4B0ABE5D-1FA2-45CB-AD8A-33AD95154A24Q52590137-6378B8C6-34CE-4966-9600-A840F6D2AA59Q53179454-289EE00B-3702-4066-86AC-91E43A6F4F3AQ57085435-2B8B66F2-FB2D-4743-943C-27FB9539E276Q57085749-61CA1DF8-528B-4DB9-A3F1-9FD7249B16CCQ57489055-DD88E437-A2D1-429B-AAE1-FA38B2CD1CD0Q74299110-035EF001-85E9-4847-96E8-35AA1148930CQ79928221-8764BA60-598F-41F3-B377-919318A11446Q80245443-3C75378C-84A7-4B3D-A363-BE95BD7647ACQ80254756-4455AC45-45A9-4B8B-B118-016308B7F63CQ81083369-D5B930F7-A3E3-45B7-8972-97A8B3757DECQ81791292-313EDD27-5EDB-40F9-B50A-44270E6797F1Q83069114-FBCC7AE9-0E72-4857-A958-AA36174BCA0BQ83285252-F84F4849-6360-4E2E-B41A-5D1AA2DA44CFQ83810056-E7A120D8-388F-485C-B888-EAC8544C3303Q85963525-95C587D0-F8CC-4C5B-B79F-46A905DFDD44Q86618852-0E6BADDD-A353-4246-866A-B20C2D0588F8
P50
description
Polish researcher
@en
Pools onderzoeker
@nl
polski naukowiec
@pl
taighdeoir Polannach
@ga
name
Jerzy Gąsowski
@ast
Jerzy Gąsowski
@ca
Jerzy Gąsowski
@cs
Jerzy Gąsowski
@de
Jerzy Gąsowski
@en
Jerzy Gąsowski
@es
Jerzy Gąsowski
@fr
Jerzy Gąsowski
@ga
Jerzy Gąsowski
@gl
Jerzy Gąsowski
@hr
type
label
Jerzy Gąsowski
@ast
Jerzy Gąsowski
@ca
Jerzy Gąsowski
@cs
Jerzy Gąsowski
@de
Jerzy Gąsowski
@en
Jerzy Gąsowski
@es
Jerzy Gąsowski
@fr
Jerzy Gąsowski
@ga
Jerzy Gąsowski
@gl
Jerzy Gąsowski
@hr
altLabel
Jerzy Gasowski
@en
prefLabel
Jerzy Gąsowski
@ast
Jerzy Gąsowski
@ca
Jerzy Gąsowski
@cs
Jerzy Gąsowski
@de
Jerzy Gąsowski
@en
Jerzy Gąsowski
@es
Jerzy Gąsowski
@fr
Jerzy Gąsowski
@ga
Jerzy Gąsowski
@gl
Jerzy Gąsowski
@hr
P214
P106
P1153
57195213908
P1412
P1559
Jerzy Gąsowski
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-8025-5323
P735
P7859
viaf-165762577